Poor Expression of MiR-195-5p Can Assist the Diagnosis of Cerebral Vasospasm After Subarachnoid Hemorrhage and Predict Adverse Outcomes

Overview

Journal Brain Behav

Specialty Psychology

Date 2022 Nov 9

PMID 36350075

Authors

Yong Li

Senyuan Yang

Xiaobin Zhou

Runlong Lai

Affiliations

Soon will be listed here.

Abstract

Objective: Patients with spontaneous subarachnoid hemorrhage (SAH) may develop refractory arterial cerebral vasospasm (CVS), which is the leading cause of death in SAH patients. This study explored the clinical diagnostic value of serum miR-195-5p levels in CVS after SAH (SAH + CVS) and its relationship with the prognosis of SAH + CVS.

Methods: A total of 110 patients with spontaneous SAH were divided into the SAH group (N = 62) and SAH + CVS group (N = 58), with 60 healthy subjects as controls. The clinical data of blood glucose, blood sodium fluctuation, and serum lactic acid were recorded. miR-195-5p serum level was detected by RT-qPCR and its diagnostic value on SAH + CVS was analyzed by receiver operating characteristic curve. Serum levels of PDGF/IL-6/ET-1 and their correlation with miR-195-5p were analyzed using RT-qPCR, enzyme-linked immunosorbent assay, and Pearson's method. The patient prognosis was evaluated by Glasgow Outcome Scale. The effect of miR-195-5p levels on adverse prognosis was analyzed by Kaplan-Meier method and Cox regression analysis.

Results: miR-195-5p was lowly expressed in the serum of SAH patients and lower in SAH + CVS patients. Serum miR-195-5p level assisted the diagnosis of SAH and SAH + CVS and was negatively correlated with PDGF/IL-6/ET-1 levels and was an independent risk factor together with ET-1 and blood glucose for SAH + CVS. miR-195-5p low expression predicted a higher cumulative incidence of adverse outcomes and was an independent predictor of adverse outcomes.

Conclusion: Poor expression of miR-195-5p can assist the diagnosis of SAH + CVS and predict higher adverse outcomes.

Citing Articles

MicroRNA-195-5p Inhibits Intracerebral Hemorrhage-Induced Inflammatory Response and Neuron Cell Apoptosis.

Tsai Y, Chang C, Chong Y, Wu C, Tsai H, Cheng T Int J Mol Sci. 2024; 25(19).

PMID: 39408651 PMC: 11476780. DOI: 10.3390/ijms251910321.

MicroRNAs' Role in Diagnosis and Treatment of Subarachnoid Hemorrhage.

Hasanpour Segherlou Z, Saldarriaga L, Azizi E, Vo K, Reddy R, Hosseini Siyanaki M Diseases. 2023; 11(2).

PMID: 37366865 PMC: 10297144. DOI: 10.3390/diseases11020077.

Poor expression of miR-195-5p can assist the diagnosis of cerebral vasospasm after subarachnoid hemorrhage and predict adverse outcomes.

Li Y, Yang S, Zhou X, Lai R Brain Behav. 2022; 12(12):e2766.

PMID: 36350075 PMC: 9759123. DOI: 10.1002/brb3.2766.

References

Li Y, Yang S, Zhou X, Lai R . Poor expression of miR-195-5p can assist the diagnosis of cerebral vasospasm after subarachnoid hemorrhage and predict adverse outcomes. Brain Behav. 2022; 12(12):e2766. PMC: 9759123. DOI: 10.1002/brb3.2766. View

Gulec I, Sengelen A, Karagoz-Guzey F, Onay-Ucar E, Eren B, Vahabova G . The calcimimetic R-568 attenuates subarachnoid hemorrhage-induced vasospasm through PI3K/Akt/eNOS signaling pathway in the rat model. Brain Res. 2021; 1765:147508. DOI: 10.1016/j.brainres.2021.147508. View

Etminan N, Loch Macdonald R . Neurovascular disease, diagnosis, and therapy: Subarachnoid hemorrhage and cerebral vasospasm. Handb Clin Neurol. 2020; 176:135-169. DOI: 10.1016/B978-0-444-64034-5.00009-2. View

Ghali M, Srinivasan V, Johnson J, Kan P, Britz G . Therapeutically Targeting Platelet-Derived Growth Factor-Mediated Signaling Underlying the Pathogenesis of Subarachnoid Hemorrhage-Related Vasospasm. J Stroke Cerebrovasc Dis. 2018; 27(9):2289-2295. DOI: 10.1016/j.jstrokecerebrovasdis.2018.02.017. View

Kanat A, Aydin Y . Selection of cerebral aneurysms for treatment using Guglielmi detachable coils: the preliminary University of Illinois at Chicago experience. Neurosurgery. 1999; 45(3):670-4. DOI: 10.1097/00006123-199909000-00054. View

Deng X, Liang C, Qian L, Zhang Q . miR-24 targets HMOX1 to regulate inflammation and neurofunction in rats with cerebral vasospasm after subarachnoid hemorrhage. Am J Transl Res. 2021; 13(3):1064-1074. PMC: 8014398. View

Bellapart J, Jones L, Bandeshe H, Boots R . Plasma endothelin-1 as screening marker for cerebral vasospasm after subarachnoid hemorrhage. Neurocrit Care. 2013; 20(1):77-83. DOI: 10.1007/s12028-013-9887-1. View

Dubosh N, Edlow J . Diagnosis and Initial Emergency Department Management of Subarachnoid Hemorrhage. Emerg Med Clin North Am. 2020; 39(1):87-99. DOI: 10.1016/j.emc.2020.09.005. View

Haruma J, Teshigawara K, Hishikawa T, Wang D, Liu K, Wake H . Anti-high mobility group box-1 (HMGB1) antibody attenuates delayed cerebral vasospasm and brain injury after subarachnoid hemorrhage in rats. Sci Rep. 2016; 6:37755. PMC: 5121891. DOI: 10.1038/srep37755. View

10.

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

11.

Stylli S, Adamides A, Koldej R, Luwor R, Ritchie D, Ziogas J . miRNA expression profiling of cerebrospinal fluid in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg. 2016; 126(4):1131-1139. DOI: 10.3171/2016.1.JNS151454. View

12.

Bounds K, Chiasson V, Pan L, Gupta S, Chatterjee P . MicroRNAs: New Players in the Pathobiology of Preeclampsia. Front Cardiovasc Med. 2017; 4:60. PMC: 5622156. DOI: 10.3389/fcvm.2017.00060. View

13.

Saugstad J . MicroRNAs as effectors of brain function with roles in ischemia and injury, neuroprotection, and neurodegeneration. J Cereb Blood Flow Metab. 2010; 30(9):1564-76. PMC: 2932764. DOI: 10.1038/jcbfm.2010.101. View

14.

Roederer A, Holmes J, Smith M, Lee I, Park S . Prediction of significant vasospasm in aneurysmal subarachnoid hemorrhage using automated data. Neurocrit Care. 2014; 21(3):444-50. DOI: 10.1007/s12028-014-9976-9. View

15.

Pulcrano-Nicolas A, Proust C, Clarencon F, Jacquens A, Perret C, Roux M . Whole-Blood miRNA Sequencing Profiling for Vasospasm in Patients With Aneurysmal Subarachnoid Hemorrhage. Stroke. 2018; 49(9):2220-2223. DOI: 10.1161/STROKEAHA.118.021101. View

16.

de Paiva Lopes K, Vinasco-Sandoval T, Assuncao Vialle R, Paschoal Jr F, Bastos V, Bor-Seng-Shu E . Global miRNA expression profile reveals novel molecular players in aneurysmal subarachnoid haemorrhage. Sci Rep. 2018; 8(1):8786. PMC: 5993784. DOI: 10.1038/s41598-018-27078-w. View

17.

Ren X, Wang Z, Guo C . MiR-195-5p Ameliorates Cerebral Ischemia-Reperfusion Injury by Regulating the PTEN-AKT Signaling Pathway. Neuropsychiatr Dis Treat. 2021; 17:1231-1242. PMC: 8093143. DOI: 10.2147/NDT.S297975. View

18.

Li H, Wang J, Li S, Cheng L, Tang W, Feng Y . Upregulation of microRNA‑24 causes vasospasm following subarachnoid hemorrhage by suppressing the expression of endothelial nitric oxide synthase. Mol Med Rep. 2018; 18(1):1181-1187. DOI: 10.3892/mmr.2018.9050. View

19.

Aydin M, Kanat A, Yolas C, Soyalp C, Resid Onen M, Yilmaz I . Spinal Subarachnoid Hemorrhage Induced Intractable Miotic Pupil. A Reminder of Ciliospinal Sympathetic Center Ischemia Based Miosis: An Experimental Study. Turk Neurosurg. 2019; 29(3):434-439. DOI: 10.5137/1019-5149.JTN.24446-18.1. View

20.

Wanderer S, Gruter B, Strange F, Sivanrupan S, Di Santo S, Widmer H . The Role of Sartans in the Treatment of Stroke and Subarachnoid Hemorrhage: A Narrative Review of Preclinical and Clinical Studies. Brain Sci. 2020; 10(3). PMC: 7139942. DOI: 10.3390/brainsci10030153. View